Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Global Trends in R&D 2024

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience Solutions with Apple devices
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE

Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions with Apple devices

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/
Blog
“Glocalizing” Your Commercial Forecast
Rick Johnston, PhD, Senior Software Solutions Principal, Consulting Services, IQVIA
Alex Tataru, Manager, Consulting
Mar 18, 2021
  • Blogs
  • "Glocalizing" Your Commercial Forecast

Thirty years ago, the pharma industry derived most of its revenues from North America and Europe. But over the past 15 years, rising demand for innovative therapies in emerging markets has shifted the landscape. From 2005-2015 most big pharma companies saw Asia Pacific and emerging markets expand to comprise at least 25% of their total revenuesi.

This has complicated forecasting efforts, since data access and data quality are often lower in emerging markets. And assumptions that are true for America and Europe just don’t resonate in many areas of the world. For example, an IQVIA report from March 2017 looked at the impact of digital communication on uptake in every market. The study found 94% of Japan’s specialist physicians felt their preferred amount of digital communication was being achieved, however, this figure was just 50% in the US and 17% in the UK.ii.

The average global-level forecast is not able to manage this type and scale of variance by market. Doing it requires global-local collaboration as well as technology platforms that explicitly adapt big picture trends for local needs.

When global-only forecasts fall short

A centrally-generated forecast offers stakeholders a broad view of the market landscape. Oftentimes, these are produced by global experts with access to big datasets and who generate sophisticated forecast funnels based on a detailed understanding of the product. It’s an excellent foundation, but in today’s heterogeneous product landscape, it’s only the beginning.

Country-level forecasts bring more nuanced perspective from local experts. These regional affiliates are ‘on the ground’ and often have a better sense of what’s really happening in their market. But getting this regional affiliate perspective has been difficult. Global team members may find themselves making calls and sending emails, or shepherding country affiliates through a cumbersome ‘forecast submission’ process. Alternatively, local affiliates may find that their view of the market does not align well with the global standard – perhaps it is too simplistic or too complex. As a result, some build ‘shadow copies’ of commercial forecasts that have inputs and assumptions that reflect their own needs. These ‘shadow’ forecasts may never be seen by global groups, meaning valuable insights may be lost and teams are not aligned on actual goals.

But there are better ways for local and global teams to collaborate.

The future: Glocal Forecasting platforms

“Glocal” forecasting platforms are an emerging trend in pharma forecasting. This new type of forecasting technology offers collaborative platforms that allow flexible frameworks and real-time access to the same information and insights.

In these models, the global and local teams work together to build an accurate forecast. In many cases, the global team will provide a forecast framework and identify the metrics that should be tracked consistently across all markets. But within that framework, affiliates can use their own local research to adjust the forecast projections and to customize certain parts of the funnel for their individual markets. Under this model, teams benefit from maintaining a single source of truth at the global and local level.

For example, if the global forecast projects revenues based on an assumed net price discount that isn’t applicable for a local market, local affiliates can quickly update those metrics. They can also add custom parameters that are applicable only to their market – like the reimbursement landscape – while being consistent with a common global structure. Both teams get the best of both worlds: global consistency of structure, with local accuracy of insights.

When selecting a platform to support ‘glocal’ forecasting, pharma companies should look for a solution that can:

  • Be able to integrate company and real-world data sources easily into the forecast
  • Use a simple user interface that both forecasting experts and generalists can utilize comfortably to reduce forecast cycle-time.
  • Allow multiple users (global and local) to update forecasts in parallel and in real-time
  • Support various commercial forecast models for different products, indications and markets
  • Maintain a common forecast framework while allowing customization where needed – preferably able to handle both pipeline and inline products
  • Include analytics and output capabilities such as what-if scenarios, market event modeling, uncertainty analysis and visual output dashboards

The right solution will bring greater transparency and accuracy to the forecasting process, and ensure you are leveraging the knowledge of every expert in your organization.

To learn more about glocal forecasting, check out our webcast: Make Your Commercial Forecasting “Glocal” – Best Practices for Integrating Local and Global Market Forecasts or contact ForeastHorizon@iqvia.com

 

i Science Direct; “The changing model of big pharma: impact of key trends” (2016);

ii IQVIA: Channel preference versus promotional reality: The core challenge of multichannel marketing

Related solutions

Forecast Horizon

Designed specifically for the challenges and modeling approaches of the life sciences industry

Commercialization

Take advantage of the latest tools, techniques, and deep healthcare expertise to create scalable resources, precision insights, and actionable ideas.

Contact Us